Dr. Fussell represents a diverse array of clients in various intellectual property matters, including patent and trademark prosecution and litigation. She performs due diligence, freedom-to-operate, validity, and patentability analyses in the chemical and life sciences industries. She has a wide range of experience in the biotechnology, pharmaceutical, and chemical arts, including medical devices, biofuels, probiotics, plants, herbicides, fertilizers, seeds, nucleic acids, proteins, enzymes, carbohydrates, diagnostics, methods of treating cancer, cancer diagnostics, and agents for treating cancer. Dr. Fussell has negotiated and drafted a wide variety of agreements relating to intellectual property interests, including settlement agreements.
Hear from inventors from the National Cancer Institute and the Frederick National Laboratory about technologies primed for commercialization and/or collaboration; great opportunity for biotech stakeholders and companies of all sizes, [….]
“Fiscal Year 2021 was an extraordinary one for Johns Hopkins Technology Ventures despite the challenges of the pandemic,” Executive Director Christy Wyskiel told BioBuzz in an email. “We took full advantage of the momentum from the last few years.”
Over the recent decades, cancer immunotherapy research has made significant advances. In our continued quest to cure cancer, a commercial incentive is necessary to counterbalance the costs and risks associated with the research and development of cancer immunotherapies and to encourage new inventions.
Intellectual Property / Tech Law Firm McBee, Moore & Vanik Reaches #13 On Top Patent Firms List In Biotechnology & Organics Field
Intellectual Property / Tech Law Firm McBee, Moore & Vanik Reaches #13 On Top Patent Firms List In Biotechnology & Organics Field McBee, Moore & Vanik Had 247 Patents Issued [….]